Atlas Trials

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Clinical trial NCT01465659 · COMPLETED

Trial details

NCT number
NCT01465659
Sponsor
Northwestern University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Alpha Cell CarcinomaPancreatic Beta Islet Cell CarcinomaPancreatic Delta Cell CarcinomaPancreatic G-cell CarcinomaRecurrent Islet Cell Carcinoma
Start date
2011-12-12
Primary completion
2018-07-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.